...developing novel compounds for the China market, but that do not have an ex-China strategy. Huya Bioscience International LLC...
...also developing China-sourced therapeutics outside of China, but for cardiovascular disease as well as cancer. Huya...
...Calif. Crown Bioscience International Inc. (TPEx:6554), Taipei, Taiwan Galena Biopharma Inc. (NASDAQ:GALE), San Ramon, Calif. Huya...

...variety of companies. As a group, top PPP-producing biotech companies such as Evotec AG and Huya Bioscience International LLC...
...Calif. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Horizon Discovery Group plc (LSE:HZD), Cambridge, U.K. Huya Bioscience International LLC...

...the cardiovascular center of excellence at Quintiles Transnational Holdings Inc. (NYSE:Q). Sharp was CFO at Huya Bioscience International LLC...

...The university granted Huya exclusive, ex-Chinese rights to undisclosed immuno-oncology compounds that inhibit indoleamine 2,3-dioxygenase (INDO...
...2,3-dioxygenase (INDO; IDO). The partners did not respond to inquiries. Fudan University , Shanghai, China Huya Bioscience International LLC...

...for cancer indications in Japan, South Korea, Thailand, Malaysia, Indonesia, the Philippines, Vietnam and Singapore. Huya...
...non-Hodgkin’s lymphoma (NHL) in Japan, and Eisai will develop the product for solid tumor indications. Huya...
...and Taiwan to treat cancer. Gold NanoTech Inc. (Taipei, Taiwan) holds exclusive rights in Taiwan. Huya...

...Diego, Calif.) granted Eisai Co. Ltd. (Tokyo:4523) exclusive rights to HBI-8000 in several Asian territories. Huya...
...in China as Epidaza chidamide to treat relapsed or refractory peripheral T cell lymphoma (PTCL). Huya...
...and Singapore. Huya is eligible for $280 million in upfront and milestone payments, plus royalties. Huya...

...EVP, COO and co-founder of Hip Innovation Technology LLC (Plantation, Fla.). Oncology and cardiovascular play Huya Bioscience International LLC...

...Gold NanoTech has exclusive rights to the small molecule histone deacetylase (HDAC) inhibitor in Taiwan. Huya...
...Chipscreen to the compound outside of China and Taiwan. Gold NanoTech Inc. , Taipei, Taiwan Huya Bioscience International LLC...